Free Trial

Alpha Teknova (TKNO) Competitors

$2.17
+0.27 (+14.21%)
(As of 07/19/2024 ET)

TKNO vs. CODX, AXDX, ACHV, VNRX, ABIO, ICCC, OCX, TRIB, AWH, and CDIO

Should you be buying Alpha Teknova stock or one of its competitors? The main competitors of Alpha Teknova include Co-Diagnostics (CODX), Accelerate Diagnostics (AXDX), Achieve Life Sciences (ACHV), VolitionRx (VNRX), ARCA biopharma (ABIO), ImmuCell (ICCC), OncoCyte (OCX), Trinity Biotech (TRIB), Aspira Women's Health (AWH), and Cardio Diagnostics (CDIO). These companies are all part of the "medical" sector.

Alpha Teknova vs.

Co-Diagnostics (NASDAQ:CODX) and Alpha Teknova (NASDAQ:TKNO) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their analyst recommendations, risk, earnings, community ranking, institutional ownership, media sentiment, dividends, valuation and profitability.

Co-Diagnostics has a beta of -0.82, indicating that its share price is 182% less volatile than the S&P 500. Comparatively, Alpha Teknova has a beta of 0.33, indicating that its share price is 67% less volatile than the S&P 500.

In the previous week, Alpha Teknova had 7 more articles in the media than Co-Diagnostics. MarketBeat recorded 7 mentions for Alpha Teknova and 0 mentions for Co-Diagnostics. Co-Diagnostics' average media sentiment score of 0.95 beat Alpha Teknova's score of 0.00 indicating that Alpha Teknova is being referred to more favorably in the news media.

Company Overall Sentiment
Co-Diagnostics Neutral
Alpha Teknova Positive

Co-Diagnostics presently has a consensus target price of $2.00, suggesting a potential upside of 57.48%. Alpha Teknova has a consensus target price of $5.00, suggesting a potential upside of 130.41%. Given Co-Diagnostics' stronger consensus rating and higher probable upside, analysts plainly believe Alpha Teknova is more favorable than Co-Diagnostics.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Co-Diagnostics
0 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
2.00
Alpha Teknova
0 Sell rating(s)
1 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.50

15.0% of Co-Diagnostics shares are owned by institutional investors. Comparatively, 13.8% of Alpha Teknova shares are owned by institutional investors. 2.4% of Co-Diagnostics shares are owned by company insiders. Comparatively, 15.2% of Alpha Teknova shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Co-Diagnostics received 265 more outperform votes than Alpha Teknova when rated by MarketBeat users. Likewise, 63.19% of users gave Co-Diagnostics an outperform vote while only 36.36% of users gave Alpha Teknova an outperform vote.

CompanyUnderperformOutperform
Co-DiagnosticsOutperform Votes
273
63.19%
Underperform Votes
159
36.81%
Alpha TeknovaOutperform Votes
8
36.36%
Underperform Votes
14
63.64%

Alpha Teknova has a net margin of -97.85% compared to Alpha Teknova's net margin of -582.36%. Co-Diagnostics' return on equity of -38.24% beat Alpha Teknova's return on equity.

Company Net Margins Return on Equity Return on Assets
Co-Diagnostics-582.36% -42.35% -38.55%
Alpha Teknova -97.85%-38.24%-26.40%

Co-Diagnostics has higher earnings, but lower revenue than Alpha Teknova. Alpha Teknova is trading at a lower price-to-earnings ratio than Co-Diagnostics, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Co-Diagnostics$6.46M6.15-$35.33M-$1.32-0.96
Alpha Teknova$36.68M2.41-$36.78M-$1.05-2.07

Summary

Alpha Teknova beats Co-Diagnostics on 12 of the 18 factors compared between the two stocks.

Get Alpha Teknova News Delivered to You Automatically

Sign up to receive the latest news and ratings for TKNO and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding TKNO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

TKNO vs. The Competition

MetricAlpha TeknovaDiagnostic substances IndustryMedical SectorNASDAQ Exchange
Market Cap$88.58M$2.74B$5.41B$8.40B
Dividend YieldN/A0.70%2.81%3.93%
P/E Ratio-2.07188.64169.0318.26
Price / Sales2.4167.752,168.1187.29
Price / CashN/A18.4236.3034.86
Price / Book0.983.724.874.45
Net Income-$36.78M$30.88M$111.24M$216.15M
7 Day Performance69.53%1.50%-0.64%-0.12%
1 Month Performance52.82%3.32%7.47%5.59%
1 Year Performance-38.70%-26.66%4.08%1.31%

Alpha Teknova Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
CODX
Co-Diagnostics
3.3743 of 5 stars
3.37 / 5 stars
$1.27
-1.6%
$2.00
+57.5%
-15.9%$39.73M$6.81M-0.96155
AXDX
Accelerate Diagnostics
2.3326 of 5 stars
2.33 / 5 stars
$1.13
-2.6%
$1.00
-11.5%
-83.1%$24.92M$12.06M-0.28220Analyst Forecast
ACHV
Achieve Life Sciences
1.7713 of 5 stars
1.77 / 5 stars
$4.76
-2.1%
$14.00
+194.1%
-12.3%$163.46MN/A-3.6922Positive News
VNRX
VolitionRx
1.2025 of 5 stars
1.20 / 5 stars
$0.66
flat
$2.50
+281.7%
N/A$54.32M$770,000.00-1.42110Gap Up
ABIO
ARCA biopharma
0.2701 of 5 stars
0.27 / 5 stars
$3.31
-5.2%
N/A+61.0%$48.03MN/A-7.884Analyst Upgrade
News Coverage
Positive News
ICCC
ImmuCell
0 of 5 stars
0.00 / 5 stars
$4.20
-2.1%
N/A-21.7%$33.51M$21.28M-8.2470Positive News
OCX
OncoCyte
0.5925 of 5 stars
0.59 / 5 stars
$3.12
-5.5%
$4.06
+30.2%
-25.9%$25.80M$1.50M0.0043Analyst Forecast
News Coverage
TRIB
Trinity Biotech
0 of 5 stars
0.00 / 5 stars
$3.08
+5.5%
N/A-35.3%$23.47M$56.83M-1.10380Gap Up
AWH
Aspira Women's Health
1.1949 of 5 stars
1.19 / 5 stars
$1.49
+7.2%
$4.45
+198.7%
-62.8%$18.55M$9.15M-1.0364News Coverage
CDIO
Cardio Diagnostics
1.2031 of 5 stars
1.20 / 5 stars
$0.53
-3.6%
$2.00
+277.4%
-56.4%$12.02M$20,000.000.001Positive News
Gap Up

Related Companies and Tools

This page (NASDAQ:TKNO) was last updated on 7/20/2024 by MarketBeat.com Staff

From Our Partners